← 返回首页
美国 · 通讯社与实时数据 · PR Newswire

FINN Partners releases new whitepaper highlighting challenges for scaling the UK and European biotech and biopharma industry

来源:PR Newswire · 美国 16 分钟前
FINN Partners releases new whitepaper highlighting challenges for scaling the UK and European biotech and biopharma industry
PR Newswire

详细摘要

Whitepaper released as part of London Life Sciences Week explores what is needed to overcome the challenges facing biotech and biopharma in the UK and Europe. FINN Partners sets…

LONDON, Nov. 16, 2026 /PRNewswire/ -- Global independent marketing and communications firm FINN Partners has released a landmark whitepaper The Future of Biotech and Biopharma in the UK & Europe, published to coincide with London Life Sciences Week 2026.

The whitepaper analyses the structural barriers standing in the way of UK and continental European life science companies from becoming globally dominant market players.

Sophie Taylor-Roberts, managing partner and UK health lead, FINN Partners, said: "UK and European life sciences ecosystems generate world-class innovations, but as we know scientific excellence is not enough on its own to guarantee commercial success. To redress the balance, we need to eliminate the transatlantic scaling gap."

"As investors and life sciences leaders meet at London Life Sciences Week, our whitepaper examines the impact of cross-border manufacturing bottlenecks, addresses the realities of NHS and single-payer reimbursement, and provides a framework for what needs to be done to ensure the future success of the industry in the UK and Europe."

The whitepaper looks specifically at the problem of transatlantic capital deficiency and scaling, overcoming post-Brexit difficulties in manufacturing of the product due to CDMO logistics, and addressing health technology assessments (HTAs) in the UK and European single-payer markets. It also focusses on mitigating the risks related to health data security in the era of generative artificial intelligence and machine learning technologies.

How to surmount structural growth challenges: Though the "Golden Triangle" of the UK (Oxford, Cambridge, London) and research clusters in Europe including BioRN, Basel and Medicon Valley generate world-class scientific research, there are often difficulties with growth financing and lab space shortages. The whitepaper suggests creating a "connected density" across Europe to establish an efficient ecosystem of capital, talent and fluid infrastructure.

Fortifying supply…

P…

文章开头,摘自PR Newswire。如需阅读全文,请前往媒体网站。

在 PR Newswire 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.prnewswire.com)

推荐阅读